Page 6,100«..1020..6,0996,1006,1016,102..6,1106,120..»

Store-A-Tooth™ Dental Stem Cell Banking Featured at Greater New York Dental Meeting

Posted: Published on November 22nd, 2012

Provia Labs Store-A-Tooth dental stem cell banking will be featured as a new product at this weeks Greater New York Dental Meeting (GNYDM), exhibiting at booth #3333 to showcase their service and announce their initiative to support diabetes research, Stem Cells for a Cure. Lexington, MA (PRWEB) November 21, 2012 Dental professionals play an important role in spreading awareness about this option, to give patients the choice to bank their own stem cells from teeth that would otherwise be discarded during routine dental care. By incorporating the Store-A-Tooth service into their practices, the dental community has the unique opportunity to play a key role in their patients overall health, not just their oral health. Attendees at the Greater New York Dental Meeting can find out more by visiting Store-A-Tooth at Booth #3333. The company partners with dental offices to educate patients about the option to bank their familys stem cells. For those interested in the service, Store-A-Tooth makes it easy for patients and their dentists to collect teeth removed during normal dental procedures, such as when baby teeth come loose, wisdom teeth are extracted, or teeth are pulled for orthodontia. Samples are sent overnight to a state-of-the-art laboratory where theyre … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Store-A-Tooth™ Dental Stem Cell Banking Featured at Greater New York Dental Meeting

Clinical implantation of chondrotissue® with concomitant surgical procedures – Video

Posted: Published on November 22nd, 2012

Clinical implantation of chondrotissue with concomitant surgical procedures This treatment video (by courtesy of Dr. Harold Vanderschmidt) includes partial resection of the lateral meniscus, ACL reconstruction with BTB graft, and the implantation of chondrotissue. For this purpose the cartilage defect was debrided up to the subchondral bone and then microfractured to allow the migration of mesenchymal stem cells into the scaffold. After measuring the defect size with a sterile template, the rehydrated chondrotissue was cut to fit the defect size, was implanted through a transpatellar portal and was fixed with fibrin glue.From:BioTissueAGViews:4 0ratingsTime:00:55More inPeople Blogs Read more: Clinical implantation of chondrotissue® with concomitant surgical procedures - Video … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Clinical implantation of chondrotissue® with concomitant surgical procedures – Video

All Wales Strategic Medical Group Approves Zebinix® (Eslicarbazepine Acetate) – Once Daily Anti-Epileptic Treatment

Posted: Published on November 22nd, 2012

HATFIELD, England, November 22, 2012 /PRNewswire/ -- The All Wales Strategic Medical Group (AWSMG) has approved Zebinix (eslicarbazepine acetate) for the treatment of partial seizures in highly refractory patients who remain uncontrolled with, or are intolerant to, other anti-epileptic medicine combinations. Eslicarbazepine acetate is licenced in Europe as an adjunctive therapy for adults with partial-onset seizures with or without secondary generalisation.[1] "There are 32,000 people in Wales living with epilepsy. Epilepsy is a complex condition which can be very difficult to treat. Up to 70 per cent of people with epilepsy could have their seizures controlled but only 52 per cent actually do. We welcome the decision by the AWSMG to make Zebinix available as an add-on treatment for people with difficult to control epilepsy who could benefit from this epilepsy medicine," commented Ann Sivapatham, Epilepsy Action's Wales Manager. Epilepsy affects nearly 32,000 people in Wales.[2] The successful treatment of partial-onset seizures (the most common form of epilepsy) remains a significant challenge in some patients and the incidence of uncontrolled partial epilepsy remains high, between 20 - 40% of patients with epilepsy have remained poorly controlled despite these treatments, despite many existing anti-epileptic drugs (AEDs).[3] Nick Burgin, Director Market Access, … Continue reading

Comments Off on All Wales Strategic Medical Group Approves Zebinix® (Eslicarbazepine Acetate) – Once Daily Anti-Epileptic Treatment

'Fat' drug could treat epilepsy

Posted: Published on November 22nd, 2012

21 November 2012 Last updated at 09:02 ET A substance made by the body when it uses fat as fuel could provide a new way of treating epilepsy, experts hope. Researchers in London who have been carrying out preliminary tests of the fatty acid treatment, report their findings in Neuropharmacology journal. They came up with the idea because of a special diet used by some children with severe, drug resistant epilepsy to help manage their condition. The ketogenic diet is high in fat and low in carbohydrate. The high fat, low carbohydrate diet is thought to mimic aspects of starvation by forcing the body to burn fats rather than carbohydrates. The identification of these fatty acids is an exciting breakthrough Although often effective, the diet has attracted criticism, as side-effects can be significant and potentially lead to constipation, hypoglycaemia, retarded growth and bone fractures. By pinpointing fatty acids in the ketogenic diet that are effective in controlling epilepsy, researchers hope they can develop a pill for children and adults that could provide similar epilepsy control without the side-effects. In early trials, the scientists, from Royal Holloway and University College London, say they have identified fatty acids that look like good … Continue reading

Comments Off on 'Fat' drug could treat epilepsy

Discovery offers new treatment for epilepsy

Posted: Published on November 22nd, 2012

ScienceDaily (Nov. 21, 2012) New drugs derived from components of a specific diet used by children with severe, drug-resistant epilepsy could offer a new treatment, according to research published today in the journal Neuropharmacology. Scientists from Royal Holloway, in collaboration with University College London, have identified specific fatty acids that have potent antiepileptic effects, which could help control seizures in children and adults. The discovery could lead to the replacement of the ketogenic diet, which is often prescribed for children with severe drug-resistant epilepsy. The high fat, low carbohydrate diet is thought to mimic aspects of starvation by forcing the body to burn fats rather than carbohydrates. Although often effective, the diet has attracted criticism, as side effects can be significant and potentially lead to constipation, hypoglycaemia, retarded growth and bone fractures. By pinpointing fatty acids in the ketogenic diet that are effective in controlling epilepsy, researchers hope that they can develop a pill for children and adults that could provide similar epilepsy control, but lacks the side effects of the diet. Professor Robin Williams from the Centre of Biomedical Sciences at Royal Holloway said: This is an important breakthrough. The family of medium chain fatty acids that we have … Continue reading

Comments Off on Discovery offers new treatment for epilepsy

New hope for understanding autism spectrum disorders

Posted: Published on November 22nd, 2012

Public release date: 21-Nov-2012 [ | E-mail | Share ] Contact: William Raillant-Clark w.raillant-clark@umontreal.ca 514-343-7593 University of Montreal This press release is available in French. Researchers from McGill University and the University of Montreal have identified a crucial link between protein synthesis and autism spectrum disorders (ASD), which can bolster new therapeutic avenues. Regulation of protein synthesis, also termed mRNA translation, is the process by which cells manufacture proteins. This mechanism is involved in all aspects of cell and organism function. A new study in mice has found that abnormally high synthesis of a group of neuronal proteins called neuroligins results in symptoms similar to those diagnosed in ASD. The study also reveals that autism-like behaviors can be rectified in adult mice with compounds inhibiting protein synthesis, or with gene-therapy targeting neuroligins. Their results are published in the journal Nature. Autism spectrum disorders (ASD) encompass a wide array of neurodevelopmental diseases that affect three areas of behaviour: social interactions, communication and repetitive interests or behaviors. According to the U.S.-based Centers for Disease Control and Prevention, 1 in 88 children suffer from ASD, and the disorder is reported to occur in all racial, ethnic, and socioeconomic groups. ASDs are almost five … Continue reading

Comments Off on New hope for understanding autism spectrum disorders

Benefit Of Popular Autism Therapy Questioned

Posted: Published on November 22nd, 2012

New research is casting doubt on the merits of a popular autism treatment which relies on weighted vests, bouncy balls and other sensory stimuli. Researchers reviewed 25 existing studies looking at sensory integration therapy and found that the method is not scientifically supported. Rigorous, methodologically sound studies do not indicate that it helps and, in fact, the majority of studies that were reviewed reported no benefits for children with ASD, said Mark OReilly of the University of Texas at Austin who worked on the analysis, which was published in the journal Research in Autism Spectrum Disorders. Sensory integration therapy is intended to address the atypical responses that many with autism have to sight, sound, touch and other sensory stimuli. Therapists utilize swings, balls, brushes and other specially-designed tools to help those on the spectrum learn to cope. The review is not the first to question the value of sensory integration therapy. Earlier this year, the American Academy of Pediatrics issued a policy statement indicating that support is lacking for the method, but did not go so far as to advise against it. Parents should be informed that the amount of research regarding the effectiveness of sensory integration therapy is limited … Continue reading

Comments Off on Benefit Of Popular Autism Therapy Questioned

Step By Step’s Expert Testimony on Behalf of Michigan’s Autism Insurance Bill Provides Crucial Support Needed for Its …

Posted: Published on November 22nd, 2012

Step By Steps testimony in support of the new state legislation helps to bring insurance reform to Michigan families affected by Autism Spectrum Disorder. Worthington, Ohio (PRWEB) November 20, 2012 Michele LaMarche, BCBA, executive director and Morgan Aue-VanDenBerg, BCBA, clinic director at Step By Step, a native of Michigan and a graduate of the Western Michigan Universitys Board Certified Behavior Analyst program, was asked by Michigans Lieutenant Governor earlier this year to provide testimony in support of the bill. The new legislation makes Applied Behavior Analysis (ABA), a highly-effective evidence based therapy used in early intervention programs, more affordable and feasible for families with children affected by ASD. I hope that my testimony, on behalf of Step By Step, helped bring access to those in Michigan who need treatment, and I hope this will lead to the passing of similar legislation in other states, Aue-VanDenBerg said. There is a huge need everywhere for autism funding, treatment and services. Because of this bills passing, we can now help families get the treatment they deserve for their child or loved one who is diagnosed with autism. Step By Step, based in Worthington, Ohio, has served the greater Columbus area for more than … Continue reading

Comments Off on Step By Step’s Expert Testimony on Behalf of Michigan’s Autism Insurance Bill Provides Crucial Support Needed for Its …

Call to ensure stroke drug in PBS scheme

Posted: Published on November 22nd, 2012

Nov. 22, 2012, midnight Audrey Walsh feels like she's one of the lucky ones - her medication to ward off any signs of a stroke is free of charge. She has an irregular heart beat and needs the preventive treatment to keep her healthy. But when the 78-year-old first heard she would need a blood thinner, her immediate reaction was: "I don't want rat poison". The horror stories she had heard about various medications filled her with fear. "Fortunately I was in the care at the time of a doctor who was aware of an alternative medication, Pradaxa," Mrs Walsh said yesterday. The Fairy Meadow resident is one of 600 people in the Illawarra who receives the anticoagulant (Dabigatran) free under an early access program. The Pharmaceutical Benefits Advisory Committee in 2011 recommended it be included in the Pharmaceutical Benefits Scheme. But so far the federal government has resisted. "While the PBAC recommended listing Pradaxa, it also raised a number of concerns that require further investigation and assessment," the government health website says. "Given these concerns and the major cost associated with listing this drug on the PBS, which is estimated could be close to $1 billion over the next … Continue reading

Comments Off on Call to ensure stroke drug in PBS scheme

Learn the signs of a stroke

Posted: Published on November 22nd, 2012

After a stroke, brain cells begin to die with in four minutes. It's important to know how to identify when someone is having a stroke. Mike McNamara heads the state cardiovascular health program, and said stroke is the fourth leading cause of death in the United States and fifth leading cause of death in Montana. A stroke occurs when blood flow to the brain is interrupted. Brain cells die from lack of oxygen, causing paralysis, loss of speech, and even vision. McNamara explained, "A stroke is disruption of blood flow in the brain, either by a blood clot or by a vessel breaking and bleeding into the brain." That's why knowing the signs of stroke is so critical. The Montana Department of Public Health and Human Services says that delaying treatment can be deadly in the event of stroke. DPHHS says that the best treatment for stroke must begin within three hours from the start of symptoms. Treatment can include a drug that breaks up blood clots and prevents further brain damage. Patients who arrive by ambulance receive faster care because the hospital can prepare before the patient arrives." Anna Whiting Sorrell, the director of MT DPHHS, noted, "Recognizing stroke … Continue reading

Comments Off on Learn the signs of a stroke

Page 6,100«..1020..6,0996,1006,1016,102..6,1106,120..»